SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

LEVY JAY

(Last)

(First)

(Middle)

110 LITTLE FALLS ROAD

(Street)

FAIRFIELD

07004

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
UNIGENE LABORATORIES INC [ UGNE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chairman of the Bd.

3. Date of Earliest Transaction (Month/Day/Year)
11/30/2005

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $.01 par value	10/06/2005		G⁽¹⁾	V	250,000	D	$0	250,000⁽²⁾⁽³⁾	I	See attached footnotes.⁽²⁾⁽³⁾
Common Stock, $.01 par value								273,095⁽³⁾	D
Common Stock, $.01 par value	10/06/2005		G⁽¹⁾	V	250,000	A	$0	250,000⁽²⁾⁽³⁾	I	See attached footnotes.⁽²⁾⁽³⁾
Common Stock, $.01 par value								273,095⁽³⁾	D
Common Stock, $.01 par value	11/30/2005		G⁽⁴⁾	V	513,095⁽⁴⁾	D	$0	10,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Gift of 250,000 shares of Unigene Laboratories, Inc. common stock, par value $.01 per share (the "Common Shares"), to Jean Levy, Mr. Levy's spouse.

2. Mr. Levy disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that Mr. Levy is the beneficial owner of such securities for Section 16 or for any other purpose.

3. Immediately following Mr. Levy's gift of 250,000 Common Shares to his spouse on 10/6/05, Mr. Levy directly beneficially owned 273,095 Common Shares and indirectly beneficially owned 250,000 Common Shares, as described in Note 1.

4. Gift of 263,095 Common Shares by Mr. Levy to The W&R Levy Family Limited Partnership (the "Partnership") and a gift of 250,000 Common Shares by Jean Levy, Mr. Levy's spouse, to the Partnership.

	Jay Levy	11/30/2005
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.